Digital Health Accelerators Digital Health Today Ambassadors Digital Health Today Digital Health Today-Resources Digital Health Today Ambassadors

Digital Health Today Podcasts

Accelerating innovation and implementation of health technology
Subscribe
Advertisement

Latest Episodes

Showing 9 - 16 of 224

S2.E4: How to achieve value based healthcare in Bangladesh with Sylvana Sinha from Praava Health

In any health system, a shift to value based healthcare is a desirable outcome. Especially if it can be combined with patient-centric clinical journeys. In this episode, Sylvana Sinha, the founder and CEO of Praava Health and I discuss the barriers and challenges to achieving this vision. With her background in health policy, international law, and as an entrepreneur, we have an insightful and fact-filled discussion covering topics including: • The cultural and socio-economic backdrop of Bangladesh, the 8th most populous country in the world • The current dynamics of access and affordability facing Bangladeshis today • The barriers and inefficiencies in creating a value-based healthcare system, including lack of labs, pharmacies, and overall accountability • Lessons learned from Praava Health in addressing these challenges • How COVID accelerated the need for more technology and new value based models Sylvana Sinha Founder, Chair, & CEO Ms. Sinha is the Founder and CEO of Praava Health in Bangladesh. Praava Health is building Bangladesh’s fastest growing consumer healthcare brand and raising the bar for healthcare with a brick-and-click healthcare platform that combines digital tools with meaningful doctor-Patient relationships, quality diagnostics, and pharmacy services. In May 2020, Fast Company recognized Praava Health in its 2020 World Changing Ideas Awards, and the World Economic Forum named Praava as a Technology Pioneer in 2021. She is now poised to scale the Praava model nationally, and to deepen Praava’s brick-and-click service delivery model. Ms. Sinha built this company from scratch, largely based on inspiration derived from conversations with public health professionals, entrepreneurs, and investors in India and Asia and beyond, learning from what had worked in other markets and what made sense for Bangladesh at this moment of its economic development. Ms. Sinha is as Life Member of the Council on Foreign Relations. She also serves as a member of the World Economic Forum’s UHC2030 Private Sector Constituency and served on the Task Force on Global Advantage at the Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai. She is a graduate of Columbia Law School, where she earned a certificate from the Parker School of Comparative and International Law. She also earned a master's degree in Public Administration / International Development from Harvard's Kennedy School and her Bachelor of Arts (with honors) in Economics and Philosophy from Wellesley College and also was a Visiting Scholar at the University of Oxford studying politics, philosophy, and economics. Guest's Links and Resources Connect with Sylvana Sinha: LinkedIn Praava Health: Website | LinkedIn | Twitter | Facebook | Instagram Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Bayer G4A Takeda Roche
October 6, 2021 by Asia Pacific Edition

S2.Ep3: 17,000+ islands – Why the archipelago geography of Indonesia amplifies healthcare delivery challenges with Jonathan Sudharta from Halodoc

In this episode, we’re taking a deep dive into Indonesia. For some, the mention of this country might evoke extreme feelings. On one hand, there is the frustration of sitting in four-hour-long traffic jams in Jakarta. On the other hand, there are smiles all around when picturing a perfect holiday in Bali. But for healthcare professionals, the identity of Indonesia is dominated by the unique geography of the country – a population of 275 million people living across 6,000 islands. To help us better understand the healthcare challenges in Indonesia, which extends across more than 17,000 islands, I’m joined by one of its most visible entrepreneurs: Jonathan Sudharta, CEO of Halodoc. Founded in 2016, the company raised an $80 million Series C in 2021. In this episode, you’ll hear about: • Access and affordability challenges stemming from Indonesia’s economic development, demographics, and archipelago geography • The impact of Universal Healthcare, introduced in 2014 • The opportunity and early impact of digital health – including Halodoc – on health outcomes Jonathan Sudharta, Co-founder and CEO Jonathan Sudharta has over 15 years of professional experience in the healthcare industry, mostly in Indonesia and also abroad. Before establishing Halodoc, Jonathan held several key positions in Mensa Group, one of the leading pharmaceutical companies in Indonesia. After graduating with a Bachelor of Commerce majoring in e-Commerce from Curtin University in Perth Australia, he began his career in sales management and has grown through the ranks in the commercial side of the organization. He started as a sales representative, after which he became the Commercial Director in Mensa Group where he gained a deep understanding of the sales cycle of the business, and finally he moved up to the key position of Business Development Director to lead the commercial initiatives of the group. Born in a healthcare group family, Jonathan grew up with a lot of awareness about serving people to maintain their wellness and helping Indonesian people achieve a better living through better health. That is the main reason why he decided to establish Halodoc, whose main mission is to simplify access to healthcare through the use of technology. Indonesia’s healthcare has many critical challenges, some of these are the inequality of health services across the archipelago, time-to-service for health in the urban areas, and so on. The aforementioned challenges require a breakthrough to solve from the fundamental level, thus technology is the key to attack the problems from the roots. Guest's Links and Resources Connect with Jonathan Sudharta: LinkedIn Halodoc: Website | LinkedIn | Twitter Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Bayer G4A Takeda Roche
September 29, 2021 by Asia Pacific Edition

S2.Ep2: Adapting to the needs of 800 million people who are facing mental health challenges with Nawal Roy from Holmusk

In this episode, we speak about the global challenge of mental health. With COVID, the WHO is predicting that “the mental health impacts of the pandemic will be long term and far-reaching.” Everyone can be affected, including caregivers and clinicians. Nawal Roy is CEO of Holmusk, a leading startup helping address the global challenge of mental health through their real world evidence platform. In our conversation, we cover the following topics: • Understanding the main categories for mental health • Similarities of mental health challenges in APAC and around the world • Areas of opportunities for digital health • The current status and future needs of evidence to unlock clinical innovations Nawal Roy (Founder & CEO, Holmusk) Nawal Roy is Founder and CEO of Holmusk, bringing more than fifteen years of finance and strategy consulting experience to the helm of the company. After seeing first-hand the transformation of the finance sector driven by data and technology, Nawal decided to focus on helping transform healthcare in the same way. There is an urgent need for more behavioral health evidence and this need is what spurred Nawal to start Holmusk. Nawal carves out the strategic direction of Holmusk, leading from the front with round-the-clock hustle and infectious energy. Prior to this, Nawal was Co-Founder and CEO of HelloPay (Rocket Internet venture), and a Junior Partner at McKinsey & Company. He has served as a World Economic Value-Based Healthcare Steering Committee and co-founded Galen Growth Asia - The Asia Health Tech Connector. Having enjoyed a global career spanning from New York to Tokyo, his close involvement with markets across North America, Europe, Southeast Asia, India, and China yields uniquely diverse experience in building next generation global companies. Guest's Links and Resources Connect with Nawal Roy: LinkedIn Holmusk: Website | LinkedIn | Twitter Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Bayer G4A Takeda Roche
September 22, 2021 by Asia Pacific Edition

S2.E1. Improving the health of Asians through microbiome and personalized nutrition with Jeremy Lim from AMILI

In this episode, we start our journey for Season 2 where we explore the challenges facing APAC that can lead to innovative solutions powered by Digital Health. Jeremy Lim is a renowned health policy expert and CEO of AMILI, the first gut microbiome lab in Singapore and Southeast Asia. Through the lens of population health and public policy, Jeremy and I discuss the need for personalised nutrition and why it can improve health outcomes. Our conversation covers: • The need for an Asia-based pool of data on nutrition based on the unique cultures and food choices found across the region • Why personalised nutrition is another reason for public health to innovate beyond a “one-size fits all” approach • The challenge of successfully using nudging behaviours to improve health outcomes • When is the optimal time to understand your microbiome? Assoc Prof Jeremy Lim is Co-founder and CEO of AMILI, the region’s first precision gut microbiome company which is building up the world’s largest multi-ethnic Asia database of microbiome sequences and associated data. He brings diverse and unique perspectives into this role as a startup founder, having spent substantial time in public and private healthcare across Asia as well as in policy advisory with Singapore's Ministry of Health, the World Bank and the World Health Organization. He is also director for global health in the NUS Saw Swee Hock School of Public Health. Outside academia, Jeremy serves on the boards of various for-profit and not-for-profit organizations in different aspects of healthcare including migrant worker health, end of life care and digital health interventions. He trained in surgery and public health, attaining post-graduate qualifications in both from the UK and US.  Guest's Links and Resources Connect with Jeremy Lim: LinkedIn AMILI: Website | LinkedIn Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Bayer G4A Takeda Roche
September 15, 2021 by Asia Pacific Edition

Ep23: Conclusion: Reflecting on DTx Limited Edition Series

In this final episode of Digital Therapeutics Edition, Eugene and his journalistic partner, Brian Dolan, reflect on the lessons learned, guest experts, and inspiring stories featured in season one. Brian is a journalist and the founder and lead writer of Exits & Outcomes, and in each episode, he asked the guests a pointed and challenging question about their digital solutions or their outlook on the DTx industry.  It's been an eventful five months, Brian says -- companies have been bought, merged, and sold, and have raised impressive rounds of funding -- but there are other areas that have seen little progress since the podcast was launched. There may be a season 2 of Digital Therapeutics Edition, but in the meantime, head over to healthxl.com/dtx to continue the conversation with Eugene and other experts. What do you think the future of DTx will look like?  >>Click here to read the transcript Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

Ep22: Clinically-Validated DTx Solutions for Unmet Needs

Abhishek Shah, the CEO and founder of Wellthy Therapeutics, is driven by the challenge of improving care delivery and outcomes for serious or chronic diseases like hypertension, type 2 diabetes, and kidney disease. Abhishek decided to start Wellthy after a successful career as an investor; he was inspired by the incredible ideas of other entrepreneurs, and tired of sitting on the sidelines, decided to build something himself.  Eugene and Abhishek talked back in December, and in that time, Wellthy has laid the groundwork for expansion throughout Asia Pacific and Europe. Eugene and Abhishek talk about his efforts to get investors to back Wellthy, the technology and regulatory landscape for DTx in South Asia, and whether Wellthy is facing competition from other industry players like Apollo during the COVID-19 pandemic. >>Click here to read the transcript Guest Links and Resources: Connect with Abhishek Shah: LinkedIn | Twitter Visit Wellthy Therapeutics: Twitter | LinkedIn | Facebook | Instagram | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

Ep21: Investing in Prescription DTx

Edward Kliphuis says his love for investing in digital health comes from his love of "playing with toys" and imagining the possible benefit to health outcomes if "damn cool" solutions are scaled significantly.  M Ventures backs many impressive companies-- like BioLink, Sonde Health, and Akili. In this episode, Ed talks to Eugene about M Ventures' founding philosophy (how to cut delayed feedback cycles, which M Ventures views as the biggest threat to humanity), approach to investing, and discusses some of the drivers of capital injections in the DTx space. Also, Ed offers his insight into what makes for a truly successful DTx company. >>Click here to read the transcript Guest Links and Resources: Connect with Edward Kliphuis: LinkedIn Visit Amadeus Capital Partners: Twitter | LinkedIn | Website Visit M Ventures: LinkedIn | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

Ep20: Investing in DTx Businesses

Will Gibbs came to Octopus Ventures via a circuitous route - which interestingly, included setting up a rare breed pig farm in his native Essex. He landed in venture capital because he loves to build things - especially large-scale solutions for "taboo" or overlooked medical conditions like substance addiction, menopause, and acne.  Will and Eugene peek underneath the hood of venture capital. They discuss Octopus Ventures' investments in companies like Big Health and Quit Genius, the ins and outs of investing in DTx solutions, whether there is a valuation bubble in the DTx space, and Will offers some advice for startups looking to raise funds. >>Click here to read the transcript Viewing in Apple Podcasts? Visit our website for links to everything below: https://digitalhealthtoday.com/dtx/ Guest Links and Resources: Connect with Will Gibbs: LinkedIn https://linkedin.com/in/willgibbs1/ Visit Octopus Ventures: Twitter | LinkedIn | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche
Prev Next Showing 9 - 16 of 224
cover
Digital Therapeutics Alliance (DTA) The Next Chapter in Scaling the DTx Industry
X
X